On November 2, 2015, the U.S. International Trade Commission (“Commission”) issued a press release announcing their vote to institute an investigation of Certain Blood Cholesterol Test Strips and Associated Systems Containing Same (Inv. No. 337-TA-969).
The investigation is based on an October 2, 2015 complaint filed by Polymer Technology Systems, Inc. of Indianapolis, Indiana alleging violation of Section 337 in the importation into the U.S. and sale of certain blood cholesterol test strips and associated systems containing same that infringe one or more claims of U.S. Patent No. 7,087,397. See our October 6, 2015 post for more details on the complaint.
According to the Notice of Investigation, the Commission has identified Infopia Co., Ltd. of South Korea, Infopia America LLC of Titusville, Florida, and Jant Pharmacal Corp. of Encino, California as the respondents.
Lastly, Chief ALJ Bullock issued a notice indicating that Thomas B. Pender will be the presiding Administrative Law Judge in this matter.